drugset / Trial / NCT00956761

Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

NCT00956761 ↗

Phase 2 Completed 63 enrolled Novartis Novartis Vaccines · collab
NaSingle-groupOpen-labelPrevention

Summary

This is a trial for annual registration of the updated seasonal influenza vaccine formulation.

Timeline

Start
2009-06
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Seasonal Influenza Vaccine (MF59C.1) Vaccine — —

Indications